About Invent Bio
Invent Bio was a Healthcare company based in Andheri (India) founded in 2005 by Ravi Shankar Srivastava. It provides a portfolio of interventional cardiovascular medical devices. It operates on a B2B model. Invent Bio has raised $792.77 thousand across 3 funding rounds from investors including Ladderup, Murgesan Madurai Veeran Devendran and Zang Qui. The company has 15 employees. Invent Bio was last valued at $132.05 million in February 2011. Its Indian entity Invent Bio-Med Private Limited reported revenue of ₹20.39 Cr. The company is recorded as dissolved. Its focus areas include Medical Devices, Cardiovascular and Interventional Devices.
Company details
Invent Bio provides a portfolio of interventional cardiovascular medical devices, focusing on providing healthcare solutions, developing medical devices, cardiovascular, and interventional devices. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Andheri, India
- Employees 15
- Founders Ravi Shankar Srivastava
- Stage Minicorn
- SectorsHealthcare
- Website inventbio-med.com
- Social X Facebook
- Legal Name Invent Bio-Med Private Limited
- Date of Incorporation 03 May, 2005
- Annual Revenue₹20.39 Cr
FY 2025 · +37% YoY
- Net Profit₹2.29 Cr
FY 2025 · 11% margin
- EBITDA₹4.60 Cr
FY 2025 · 23% margin
- Total Equity Funding$792.77K (USD)
in 3 rounds
- Latest Funding Round$44.02K (USD), Angel Round
Feb 2011
- InvestorsLadderup
& 15 more
- Employee Count15
Associated legal entities of Invent Bio
Invent Bio operates through Invent Bio-Med Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Invent Bio-Med Private Limited CIN U33110MH2005PTC152988 | Active | 03 May 2005 | Mumbai, Maharashtra | ₹20.4 Cr | 15 | 5 | View details |
Funding Insights of Invent Bio
Invent Bio has successfully raised a total of $792.77K across 3 strategic funding rounds. The most recent funding activity was a Angel Round of $44.02 thousand completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $792,767
- Total Rounds 3
- Last Round Angel Round — $44,024
- First Round $416,920
(Aug 2007)
- Investors Count 15
All 3 funding rounds of Invent Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2011 | $44,024 | Angel Round | $2.93M | Murgesan Madurai Veeran Devendran | – |
| Aug 2009 | $331,823 | Angel Round | $3.2M | Murgesan Madurai Veeran Devendran | |
| Aug 2007 | $416,920 | Seed | $••••• | Ashok R Thakrar |
| Date | Valuation | Stage |
|---|---|---|
| Feb 2011 | $2.93M | •••••••• |
| Aug 2009 | $3.2M | •••••••• |
| Aug 2007 | $••••• | •••••••• |
Full valuation and stage history of Invent Bio
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $132.05M (Feb 2011). 16 investors in total: 1 institutional and 15 angel.
Investors in Invent Bio
Invent Bio has secured backing from 16 investors, including angel and institutional investors. Prominent investors backing the company include Ladderup, Murgesan Madurai Veeran Devendran and Zang Qui.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Boutique investment bank focused on middle market | 1993 | ladderup.com | Mumbai, India | |
MM Murgesan Madurai Veeran Devendran | unknown_f9d5c16eb707415a9 | |||
ZQ Zang Qui | unknown_525e7d97229640ec9 | |||
PP Praful Parikh | unknown_120033ba2c5c46b8b | |||
NR Nivedita Ravishankar Srivastava | unknown_b625122b1ee34ee8b | |||
RS Ravi Shankar Srivastava | Angel investor and tech leader, ex-Amazon, focused on Indian startups | unknown_e810e7552dce4bf1a | ||
JA Jay Acharya | unknown_7a9f5ab8153d4377b | |||
AS Ashok Sharma | unknown_f8673fe49aac407fa | |||
AR Ashok R Thakrar | unknown_3abf3399c5c447799 | |||
JA Jayashree Ashok Tharker | unknown_29d02b4f68484a72b |
Investor details for Invent Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Invent Bio-Med Private Limited (Invent Bio)
Invent Bio-Med Private Limited is the primary company behind Invent Bio. The board of Invent Bio-Med Private Limited currently have 4 directors; the longest-serving is Rajkumar Gopilal Manglunia, appointed in 2017. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajkumar Gopilal Manglunia DIN 00248128 | Director | 08 Aug 2017 | 9 yrs 3 mo | Invent Bio-Med Private Limited |
| Ronak Manglunia DIN 07618117 | Director | 08 Aug 2017 | 9 yrs 3 mo | Invent Bio-Med Private Limited |
| Shyam Manglunia DIN 00896932 | Director | 08 Aug 2017 | 9 yrs 3 mo | Invent Bio-Med Private Limited |
| Amit Banwarilal Agrawal DIN 07587045 | Director | 16 May 2022 | 4 yrs 5 mo | Invent Bio-Med Private Limited |
People of Invent Bio
1 people are tracked at Invent Bio (1 in leadership); the tracked headcount is 15.
| Name | Role | Group |
|---|---|---|
Ravi Shankar Srivastava | Founder, Managing Director | Leadership |
Complete people profiles for Invent Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Invent Bio
Figures of Invent Bio-Med Private Limited, the primary company behind Invent Bio, for FY 2025. Revenue was ₹20.39 Cr (+37% year on year). Net profit was ₹2.29 Cr (11% margin). EBITDA was ₹4.60 Cr (23% margin). Revenue has grown at a compounded annual rate of +90% over three years and +29% over five years.
- ₹20.39 CrRevenue · FY 2025 · +37% YoY
- ₹2.29 CrNet profit · 11% margin
- ₹4.60 CrEBITDA · 23% margin
- ₹24.70 CrPaid-up capital
- 15Employees (provident fund records)
- +90%Revenue CAGR, 3 years
- +29%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Invent Bio-Med Private Limited are on its company page.
Detailed financial statements for Invent Bio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Invent Bio
4 dated milestones of Invent Bio across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Invent Bio is founded.
- Funding First funding round of $417K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $44K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Invent Bio
Complete news archive for Invent Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invent Bio
Invent Bio was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Invent Bio is headquartered in Andheri, India. It is registered at Andheri, Maharashtra, India.
Invent Bio is a funded company, having raised a total of $792.77K across 3 funding rounds to date. The company's 1st funding round was a Seed of $416.92K, raised on Aug 2007.
Invent Bio has 15 employees.
The primary company behind Invent Bio, Invent Bio-Med Private Limited, reported revenue of ₹20.39 Cr for FY 2025, up 37% year on year.
Invent Bio provides a portfolio of interventional cardiovascular medical devices, focusing on providing healthcare solutions, developing medical devices, cardiovascular, and interventional devices. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Invent Bio has 16 investors. Key investors include Ladderup, Murgesan Madurai Veeran Devendran, Zang Qui, Praful Parikh, and Nivedita Ravishankar Srivastava.
The valuation of Invent Bio is $132.05M as of Feb 2011.
Invent Bio operates through Invent Bio-Med Private Limited.
The legal entities of Invent Bio currently have 5 directors, including Sagar Rajvanshi, Rajkumar Gopilal Manglunia, Amit Banwarilal Agrawal and others.